Clariant Completes Sale of Pharmaceutical Fine Chemicals.MUTTENZ, Switzerland -- After fulfilment of local transfer requirements and approval of all relevant authorities, Clariant (SWX SWX Swiss Exchange (trademark of SWX Swiss Exchange) SWX SolidWorks (3D solid modeling CAD software) SWX Splitter / Wave Division Multiplexer :CLN CLN Clean CLN Community Learning Network CLN Colon CLN Celsion Corporation CLN Class Library for Numbers CLN Credit Linked Note CLN Comitato di Liberazione Nazionale (Committee of National Liberation) CLN Corn Lethal Necrosis ) has completed the sale of its Pharmaceutical Fine Chemicals unit to TowerBrook Capital Partners, L.P. on June 30th 2006 for a transaction value of CHF CHF In currencies, this is the abbreviation for the Swiss Franc. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 110 million. The Pharmaceutical Fine Chemicals unit, part of the Life Science Chemicals Division, is subsequently reported as discontinued operation discontinued operation A segment of a business that has been abandoned or sold or for which plans for one or another of these actions have been approved. See also continuing operations. . For an easier reconciliation you will find on our Website (Investor Relations Investor relations The process by which the corporation communicates with its investors. / Media Releases and Presentations / Supplementary Information) a restatement Restatement A revision in a company's earlier financial statements. Notes: The need for restating financial figures can result from fraud, misrepresentation, or a simple clerical error. of the 2006 and 2005 quarterly figures. Clariant - Exactly your chemistry. Clariant is a global leader in the field of specialty chemicals. Strong business relationships, commitment to outstanding service and wide-ranging application know-how make Clariant a preferred partner for its customers. Clariant, which is represented on five continents with over 100 group companies, employs about 23 000 people. Headquartered in Muttenz near Basel, it generated sales of around CHF 8.2 billion in 2005. Clariant's businesses are organized in five divisions: Textile, Leather & Paper Chemicals, Pigments & Additives, Functional Chemicals, Life Science Chemicals and Masterbatches. Clariant is committed to sustainable growth springing from its own innovative strength. Clariant's innovative products play a key role in its customers' manufacturing and treatment processes or else add value to their end products. The company's success is based on the know-how of its people and their ability to identify new customer needs at an early stage and to work together with customers to develop innovative, efficient solutions. www.clariant.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion